At the forefront of
single cell genetic analysis

RHS Ltd is a developer of advanced single cell genomic technologies with a focus on improving health and research outcomes.

News

Implementation of Scheme of Arrangement and resignation and appointment of directors

Lodgement of Federal Court orders with ASIC and suspension of trading in RHS shares

Federal Court approves RHS Scheme

Results of RHS Scheme Meeting

RHS Scheme of Arrangement

RHS Ltd is a developer of advanced single cell genomic technologies with a focus on improving health and research outcomes.

Learn more
about RHS

Feature Product

DOPlify™, the latest product from RHS, is an advanced whole genome amplification kit for limited DNA template

Learn More